BMH BRÄUTIGAM advises Earlybird on € 3.2 million round of Nosh.bio
Munich — Earlybird Venture Capital has led a €3.2 million seed funding round for Berlin-based food tech startup Nosh.bio. In addition to lead investor Earlybird Venture Capital, the American fund Clear Current Capital, Grey Silo Ventures and Good Seed Ventures participated in the round. With the fresh capital, Nosh.bio will continue to commercialize its first product, develop R&D processes and expand production capacity.
Nosh.bio was founded in 2022 by Tim Fronzek, formerly co-founder of rebuy.com, and Felipe Lino, former Novozymes researcher and global R&D manager at AB-InBev, with the goal of helping shape the food industry of tomorrow. The company uses natural, fermented mycoprotein to bring highly functional, healthy and clean-label ingredients to market at the same price as animal-based ingredients. Nosh.bio ingredients have binding, gelling and texturizing properties and are expected to replace chemical additives in the future, enabling, for example, the production of meat substitute products with a single ingredient.
BMH BRÄUTIGAM continuously advises Earlybird on investments (most recently on the financing round of Greenlyte) and was able to further strengthen and expand the client relationship.
Advisor Earlybird: BMH BRÄUTIGAM
Bastian Reinschmidt, Dr. Jan Böhle, Lisa-Marie Sarucco (all Venture Capital)
Advisor nosh.bio: Osborne Clarke